Protalix Names Gilad Mamlok as CFO and SVP
July 21, 2025
Protalix BioTherapeutics, a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system,